Showing 3621-3630 of 7016 results for "".
Personalized Risk Communication and Its Effect on CRC Screening Choice
https://reachmd.com/programs/clinicians-roundtable/personalized-risk-communication-crc-screening-choice/56442/Hypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors
https://reachmd.com/clinical-practice/cardiology/hypertrophic-cardiomyopathy-overcoming-practical-barriers-to-treatment-in-the-era-of-myosin-inhibitors/56414/Dive into practical barriers to myosin inhibitor use in HCM and learn strategies to support timely initiation and access for eligible patients.Optimizing Hair Transplant Outcomes with Medical Therapies
https://reachmd.com/programs/dermconsult/hair-transplant-outcomes-medical-therapies/49027/For patients undergoing hair transplants, adjunctive medical and regenerative therapies are essential for long-term success. Hear from Dr. Marc Avram as he reviews our current options and key considerations for patient care. Dr. Avram is a dermatologist, hair loss and transplant specialist, and ClinDecoding the Data: Early Biologic Use and Psoriatic Arthritis
https://reachmd.com/programs/living-rheum/early-biologic-use-psoriatic-arthritis/51051/Can treating psoriasis early with biologics help prevent psoriatic arthritis? The data’s promising—but it’s complicated. Join Dr. Laura Coates as she unpacks the latest research, explaining how early intervention may influence outcomes and what real-world challenges come with interpreting observatioCan FOI Help Differentiate Psoriatic Arthritis from Erosive Hand Osteoarthritis?
https://reachmd.com/programs/Audioabstracts/foi-differentiate-psoriatic-arthritis-from-erosive-hand-osteoarthritis/51046/Distinguishing psoriatic arthritis from erosive hand osteoarthritis isn’t always straightforward—but a new imaging approach may help. Tune in to hear Ryan Quigley discuss a recent study assessing fluorescence optical imaging (FOI) and its potential to improve diagnostic accuracy in this challengingRecognizing PSO-HS as a Distinct Subset with Shared Genetic Risk
https://reachmd.com/programs/dermconsult/pso-hs-subset-genetic-risk/39676/How Systemic Psoriasis Therapies Influence the Risk of New or Recurrent MACEs
https://reachmd.com/programs/dermconsult/how-systemic-psoriasis-therapies-influence-the-risk-of-new-or-recurrent-maces/32810/Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-Making
https://reachmd.com/programs/cme/partnering-with-patients-improving-first-line-treatment-selection-in-upper-gi-cancers-through-shared-decision-making/36579/Partnering with Patients: Improving First-Line Treatment Selection in Upper GI Cancers Through Shared Decision-MakingGut Microbiota and Pediatric MS: New Insights Into Potential Disease Drivers
https://reachmd.com/programs/neurofrontiers/gut-microbiota-and-pediatric-ms-new-insights-into-potential-disease-drivers/26487/A new study investigating the relationship between gut microbiota composition and pediatric-onset multiple sclerosis (MS) offers evidence that a depletion of short-chain fatty acid (SCFA) producers may play a role in the disease's pathogenesis. Discover how these findings have the potential to inforReducing Food Allergy Reactions with an Asthma Treatment
https://reachmd.com/programs/frontlines-food-allergies/reducing-food-allergy-reactions-with-an-asthma-treatment/26318/